Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Microsoft
MSFT
|
+$981M |
| 2 |
Chevron
CVX
|
+$718M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$469M |
| 4 |
Shopify
SHOP
|
+$439M |
| 5 |
Meta Platforms (Facebook)
META
|
+$401M |
Top Sells
| 1 |
Amazon
AMZN
|
+$675M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$633M |
| 3 |
Tesla
TSLA
|
+$543M |
| 4 |
Verizon
VZ
|
+$535M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$377M |
Sector Composition
| 1 | Healthcare | 19.41% |
| 2 | Technology | 16.81% |
| 3 | Consumer Staples | 11.14% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Financials | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
OYST
3901
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $80K | ﹤0.01% |
18,500
+4,300
| +30% | +$18.6K |
|
3902
Eledon Pharmaceuticals
ELDN
$157M
| $79K | ﹤0.01% |
32,173
+13,700
| +74% | +$33.6K |
|
3903
NanoVibronix
NAOV
$4.65M
| $79K | ﹤0.01% |
57
-77
| -57% | -$107K |
|
3904
Cipher Mining
CIFR
$4B
| $78K | ﹤0.01% |
56,800
-269,937
| -83% | -$371K |
|
3905
Upexi
UPXI
$324M
| $78K | ﹤0.01% |
+930
| New | +$78K |
|
|
LHDX
3906
DELISTED
Lucira Health, Inc. Common Stock
LHDX
| $78K | ﹤0.01% |
+41,800
| New | +$78K |
|
|
BLCT
3907
DELISTED
BlueCity Holdings Limited American Depositary Shares
BLCT
| $78K | ﹤0.01% |
52,700
+29,500
| +127% | +$43.7K |
|
3908
Redwire
RDW
$1.18B
| $77K | ﹤0.01% |
+25,480
| New | +$77K |
|
|
FGNX
3909
Fundamental Global
FGNX
$9.3M
| $76K | ﹤0.01% |
2,091
+16
| +0.8% | +$582 |
|
3910
Newegg Commerce
NEGG
$737M
| $76K | ﹤0.01% |
+1,036
| New | +$76K |
|
|
XIN
3911
DELISTED
Xinyuan Real Estate
XIN
| $76K | ﹤0.01% |
9,480
-50
| -0.5% | -$401 |
|
3912
SELLAS Life Sciences
SLS
$195M
| $75K | ﹤0.01% |
+33,838
| New | +$75K |
|
3913
cbdMD
YCBD
$6.13M
| $75K | ﹤0.01% |
475
+215
| +83% | +$33.9K |
|
3914
Edesa Biotech
EDSA
$17.2M
| $74K | ﹤0.01% |
6,607
-5,222
| -44% | -$58.5K |
|
3915
Ekso Bionics
EKSO
$10.2M
| $74K | ﹤0.01% |
2,974
+1,801
| +154% | +$44.8K |
|
3916
Intelligent Bio Solutions
INBS
$15.2M
| $74K | ﹤0.01% |
466
+185
| +66% | +$29.4K |
|
3917
Mediaco Holding
MDIA
$76.2M
| $74K | ﹤0.01% |
35,100
-25,600
| -42% | -$54K |
|
|
EQOS
3918
DELISTED
EQONEX LIMITED Ordinary Shares
EQOS
| $74K | ﹤0.01% |
88,659
+57,459
| +184% | +$48K |
|
3919
Blue Hat Interactive Entertainment Technology
BHAT
$12.5M
| $73K | ﹤0.01% |
255
+54
| +27% | +$15.5K |
|
3920
KORE Group Holdings
KORE
$36.7M
| $73K | ﹤0.01% |
+4,740
| New | +$73K |
|
3921
Mind CTI
MNDO
$24.4M
| $73K | ﹤0.01% |
30,700
-30,325
| -50% | -$72.1K |
|
3922
Oragenics
OGEN
$4.66M
| $73K | ﹤0.01% |
116
+62
| +115% | +$39K |
|
3923
Oxbridge Re Holdings
OXBR
$17M
| $73K | ﹤0.01% |
22,000
+1,118
| +5% | +$3.71K |
|
|
ATON
3924
AlphaTON Capital Corp. Common Stock
ATON
$13.5M
| $73K | ﹤0.01% |
526
-1,339
| -72% | -$186K |
|
3925
Tivic Health Systems
TIVC
$4.66M
| $73K | ﹤0.01% |
22
-50
| -69% | -$166K |
|